Navigating midlife often brings changes in various aspects of health, and for many women, this includes shifts in cholesterol and lipid profiles as they transition through perimenopause and menopause. These changes are a common concern, prompting interest in various approaches to support cardiovascular well-being.
Red clover (Trifolium pratense) is a plant source of isoflavones, compounds that have been studied for their potential influence on the body during this life stage. This article explores the current evidence regarding red clover isoflavones and their potential effects on cholesterol and other lipid markers in perimenopausal and postmenopausal women.
Understanding Cholesterol and Lipid Changes in Midlife
As women approach and enter menopause, hormonal fluctuations, particularly the decline in estrogen, can impact cardiovascular health markers. It’s common to observe changes in blood lipid profiles, which include total cholesterol, low-density lipoprotein (LDL) cholesterol (often referred to as ‘bad’ cholesterol), high-density lipoprotein (HDL) cholesterol (often called ‘good’ cholesterol), and triglycerides. These shifts can contribute to an altered cardiovascular risk profile.
Maintaining balanced lipid levels is an important aspect of overall health during this time. Many women seek information on lifestyle adjustments and complementary approaches that might support healthy lipid profiles as their bodies change.
Red Clover Isoflavones and LDL Cholesterol
Several studies have investigated the potential of red clover isoflavones to influence LDL cholesterol levels. A randomized, double-blind, placebo-controlled study found that red clover isoflavones, particularly those enriched with formononetin, were associated with lower serum LDL cholesterol [1]. Similarly, another prospective randomized placebo-controlled trial observed that isoflavones from red clover improved dyslipidemia in menopausal women [2].
A meta-analysis reviewing the effects of red clover on perimenopausal and postmenopausal women’s blood lipid profiles indicated some influence on LDL cholesterol [3]. Another systematic review and meta-analysis on red clover isoflavones and lipid profiles in perimenopausal and postmenopausal women also explored these effects [4].
Effects on Total Cholesterol and Triglycerides
Beyond LDL cholesterol, research has also looked at the broader impact of red clover isoflavones on total cholesterol and triglyceride levels. A randomized, double-blind, placebo-controlled study examined the effect of red clover isoflavones on menopausal symptoms, lipids, and vaginal cytology, noting observations regarding lipids [5].
Some studies suggest that red clover isoflavones may contribute to improvements in overall lipid profiles. For instance, a 2009 study explored the influence of red clover-derived isoflavones on serum lipid profiles in postmenopausal women [6]. The meta-analyses mentioned previously also considered total cholesterol and triglyceride levels in their comprehensive reviews of the evidence [PMID 30269660, PMID 31883666].
HDL Cholesterol and Broader Lipid Considerations
The impact of red clover isoflavones on HDL cholesterol, often considered beneficial, has also been part of the research. While some studies focus more on reductions in LDL or total cholesterol, the overall balance of lipid markers is important for cardiovascular health. A prospective randomized placebo-controlled trial from 2024 noted improvements in dyslipidemia, which encompasses the overall balance of lipids, in menopausal women using red clover isoflavones [2].
It’s important to consider that the effects observed can sometimes be modest, and individual responses may vary. Some research, such as a 2004 study, suggested modest protective effects of isoflavones from a red clover-derived dietary supplement on cardiovascular disease risk factors in perimenopausal women, noting an interaction with ApoE genotype in certain age groups [7]. This highlights the complexity of individual responses to such compounds.
Summary of Evidence Strength and Consistency
The evidence regarding red clover isoflavones and their effects on cholesterol and lipid profiles in perimenopausal and menopausal women is moderate. While several studies, including randomized controlled trials and meta-analyses, indicate potential benefits, particularly for LDL cholesterol and overall dyslipidemia [PMID 39254422, PMID 25369831, PMID 30269660, PMID 31883666], the consistency and magnitude of these effects across all lipid markers can vary.
Research in this area continues to evolve, with ongoing efforts to understand the specific mechanisms and optimal applications of red clover isoflavones. It’s worth noting that some earlier reviews also discussed the broader context of soy and red clover for mid-life and aging, providing a historical perspective on these compounds [8].
References
- Red clover isoflavones enriched with formononetin lower serum LDL cholesterol-a randomized, double-blind, placebo-controlled study. European journal of clinical nutrition, 2015
- Isoflavones obtained from red clover improve both dyslipidemia and menopausal symptoms in menopausal women: a prospective randomized placebo-controlled trial. Climacteric : the journal of the International Menopause Society, 2024
- Effects of red clover on perimenopausal and postmenopausal women’s blood lipid profile: A meta-analysis. Climacteric : the journal of the International Menopause Society, 2018
- Effects of red clover (Trifolium pratense) isoflavones on the lipid profile of perimenopausal and postmenopausal women-A systematic review and meta-analysis. Maturitas, 2020
- The effect of red clover isoflavones on menopausal symptoms, lipids and vaginal cytology in menopausal women: a randomized, double-blind, placebo-controlled study. Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2005
- Influence of red clover-derived isoflavones on serum lipid profile in postmenopausal women. The journal of obstetrics and gynaecology research, 2009
- Modest protective effects of isoflavones from a red clover-derived dietary supplement on cardiovascular disease risk factors in perimenopausal women, and evidence of an interaction with ApoE genotype in 49-65 year-old women. The Journal of nutrition, 2004
- Soy and red clover for mid-life and aging. Climacteric : the journal of the International Menopause Society, 2006
These statements have not been evaluated by the Food and Drug Administration. This information is not intended to diagnose, treat, cure, or prevent any disease. Content is for informational purposes only and is not medical advice; consult a qualified healthcare provider before starting any supplement. As an Amazon Associate we earn from qualifying purchases.
